Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

被引:0
|
作者
Nathan J. Lanning
Joshua P. Castle
Simar J. Singh
Andre N. Leon
Elizabeth A. Tovar
Amandeep Sanghera
Jeffrey P. MacKeigan
Fabian V. Filipp
Carrie R. Graveel
机构
[1] California State University,Systems Biology and Cancer Metabolism, Program for Quantitative Systems Biology
[2] Van Andel Research Institute,College of Human Medicine
[3] University of California Merced,undefined
[4] Michigan State University,undefined
来源
关键词
Triple-negative breast cancer; Metabolism; Rate-limiting enzymes; Receptor tyrosine kinase; Tyrosine kinase inhibitor; Metabolic inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Single-cell metabolic profiling uncovers new precision immunotherapy strategy in triple-negative breast cancer
    Xu, Ying
    Xiao, Yi
    Wang, Han
    Shao, Zhimin
    Jiang, Yi-Zhou
    CANCER RESEARCH, 2024, 84 (09)
  • [32] Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer
    Wang, Yaru
    Sun, Yue
    Wang, Feiran
    Wang, Hongyi
    Hu, Jing
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 169
  • [33] Exogenous Metabolic Modulators Improve Response to Carboplatin in Triple-Negative Breast Cancer
    Ho, Alyssa N.
    Kiesel, Violet A.
    Gates, Claire E.
    Brosnan, Bennett H.
    Connelly, Scott P.
    Glenny, Elaine M.
    Cozzo, Alyssa J.
    Hursting, Stephen D.
    Coleman, Michael Francis
    CELLS, 2024, 13 (10)
  • [34] Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP
    Shen, Liangliang
    O'Shea, John M.
    Kaadige, Mohan R.
    Cunha, Stephanie
    Wilde, Blake R.
    Cohen, Adam L.
    Welm, Alana L.
    Ayer, Donald E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (17) : 5425 - 5430
  • [35] Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population?
    Kaitlyn Kennard
    Meghan E. Buckley
    Lina M. Sizer
    Sharon Larson
    William B. Carter
    Thomas G. Frazier
    Ned Z. Carp
    Breast Cancer Research and Treatment, 2021, 186 : 53 - 63
  • [36] Immune and metabolic mechanisms regulate the microenvironment in triple-negative breast cancer.
    Andrieu, Guillaume
    Sebastiani, Paola
    Bertrand, Kimberly A.
    Palmer, Julie R.
    Denis, Gerald V.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 90 - 90
  • [37] Relation of Androgen Receptor Status to Metabolic Activity in Triple-Negative Breast Cancer
    Lee, Reeree
    Lee, Han-Byoel
    Paeng, Jin Chul
    Cheon, Gi Jeong
    Lee, Dong Soo
    Chung, June-Key
    Kang, Keon Wook
    Suh, Hoon Young
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [38] Triple-Negative Breast Cancer Analysis Based on Metabolic Gene Classification and Immunotherapy
    Zhou, Yu
    Che, Yingqi
    Fu, Zhongze
    Zhang, Henan
    Wu, Huiyu
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [39] Investigating intra-tumour metabolic heterogeneity in triple-negative breast cancer
    Fukano, Marina
    Deblois, Genevieve
    Zuo, Dongmei
    Martinez, Constanza
    Yang, Yang
    Ragoussis, Ioannis
    Kleinman, Claudia
    Park, Morag
    CANCER RESEARCH, 2020, 80 (23)
  • [40] Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population?
    Kennard, Kaitlyn
    Buckley, Meghan E.
    Sizer, Lina M.
    Larson, Sharon
    Carter, William B.
    Frazier, Thomas G.
    Carp, Ned Z.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (01) : 53 - 63